MoneyWorks4Me

Aarey Drugs & Pharma - Quaterly Results

30 May 2022 Evaluate
A decrease of about -32.54% in the sales to Rs. 1202.46 millions was observed for the quarter ended March 2022. The sales stood at Rs. 1782.52 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2022 is Rs. -7.54 millions as compared to Net Profit of Rs. 14.06 millions of corresponding quarter ended March 2021The Operating Profit of the company witnessed a decrease to 29.96 millions from 39.99 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1202.46 1782.52 -32.54 4926.80 3484.16 41.41 4926.80 3484.16 41.41
Other Income 11.34 16.38 -30.77 27.48 70.15 -60.83 27.48 70.15 -60.83
PBIDT 29.96 39.99 -25.08 140.15 116.53 20.27 140.15 116.53 20.27
Interest 6.10 5.56 9.71 20.00 24.32 -17.76 20.00 24.32 -17.76
PBDT 23.86 34.43 -30.70 120.15 92.21 30.30 120.15 92.21 30.30
Depreciation 4.08 2.50 63.20 19.88 9.20 116.09 19.88 9.20 116.09
PBT 19.78 31.93 -38.05 100.27 83.01 20.79 100.27 83.01 20.79
TAX 27.32 17.87 52.88 34.82 17.87 94.85 34.82 17.87 94.85
Deferred Tax -1.08 1.23 -187.80 -1.08 1.23 -187.80 -1.08 1.23 -187.80
PAT -7.54 14.06 -153.63 65.45 65.14 0.48 65.45 65.14 0.48
Equity 253.85 233.85 8.55 253.85 233.85 8.55 253.85 233.85 8.55
PBIDTM(%) 2.49 2.24 11.06 2.84 3.34 -14.95 2.84 3.34 -14.95
Peers